Published: 30 Jun 2022 | Report Code: 10248550 | Pages: 196
Global ophthalmic drug delivery system market will reach $ 30,013.7 million by 2031, growing by 6.9% annually over 2021-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population. Highlighted with 80 tables and 89 figures, this 196-page report “Global Ophthalmic Drug Delivery System Market 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Suspensions, Emulsions, Liposomes & Nanoparticles), Disease (Glaucoma, Diabetic Retinopathy, Cataract, Dry Eye Syndrome, Macular Degeneration, Diabetic Macular Edema, Refractive Issues), Setting (Hospitals, Clinics, Homecare Settings, ASCs, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global ophthalmic drug delivery system market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global ophthalmic drug delivery system market in every aspect of the classification from perspectives of Product, Dosage Form, Disease, Setting, and Region. Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pre-filled Syringes • Multidose Eyedroppers • Squeeze Dispensers • Mist Sprayers • Contact Lenses • Ocular Inserts • Intraocular Implants • Punctal Plugs • Other Products Based on Dosage Form, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Solutions • Gels • Ointments • Suspensions • Emulsions • Liposomes & Nanoparticles By Disease, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Glaucoma • Diabetic Retinopathy • Cataract • Dry Eye Syndrome • Macular Degeneration • Diabetic Macular Edema • Refractive Issues • Other Diseases By Setting, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Clinics • Homecare Settings • Ambulatory Surgical Centers (ASCs) • Other Settings Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (Israel, UAE?Saudi Arabia, South Africa and Rest of MEA) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product, Dosage Form and Setting over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Aero Pump GmbH Allergan plc. AptarGroup, Inc. Becton, Dickinson and Company Biocorp Clearside Biomedical, Inc. EyePoint Pharmaceuticals, Inc. Gaplast GmbH Gerresheimer AG Jotteq Inc. Kedalion Therapeutics, Inc. Mati Therapeutics, Inc. Nemera Nipro Corporation Ocular Therapeutix, Inc. Ocumedic, Inc. Owen Mumford Re-Vana Therapeutics Silgan Holdings Inc. Terumo Corporation Valeant Pharmaceuticals International Inc. (Bausch Health Company) West Pharmaceutical Services, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents:
1 Introduction 9 1.1 Industry Definition and Research Scope 9 1.1.1 Industry Definition 9 1.1.2 Research Scope 10 1.2 Research Methodology 13 1.2.1 Overview of Market Research Methodology 13 1.2.2 Market Assumption 14 1.2.3 Secondary Data 14 1.2.4 Primary Data 14 1.2.5 Data Filtration and Model Design 15 1.2.6 Market Size/Share Estimation 16 1.2.7 Research Limitations 17 1.3 Executive Summary 18 2 Market Overview and Dynamics 21 2.1 Market Size and Forecast 21 2.1.1 Impact of COVID-19 on World Economy 22 2.1.2 Impact of COVID-19 on the Market 25 2.2 Major Growth Drivers 27 2.3 Market Restraints and Challenges 31 2.4 Emerging Opportunities and Market Trends 34 2.5 Porter’s Fiver Forces Analysis 38 3 Segmentation of Global Market by Product 42 3.1 Market Overview by Product 42 3.2 Pre-filled Syringes 44 3.3 Multidose Eyedroppers 45 3.4 Squeeze Dispensers 46 3.5 Mist Sprayers 47 3.6 Contact Lenses 48 3.7 Ocular Inserts 49 3.8 Intraocular Implants 50 3.9 Punctal Plugs 51 3.10 Other Products 52 4 Segmentation of Global Market by Dosage Form 53 4.1 Market Overview by Dosage Form 53 4.2 Solutions 55 4.3 Gels 56 4.4 Ointments 57 4.5 Suspensions 58 4.6 Emulsions 59 4.7 Liposomes & Nanoparticles 60 5 Segmentation of Global Market by Disease 61 5.1 Market Overview by Disease 61 5.2 Glaucoma 63 5.3 Diabetic Retinopathy 64 5.4 Cataract 65 5.5 Dry Eye Syndrome 66 5.6 Macular Degeneration 67 5.7 Diabetic Macular Edema 68 5.8 Refractive Issues 69 5.9 Other Diseases 70 6 Segmentation of Global Market by Setting 71 6.1 Market Overview by Setting 71 6.2 Hospitals 73 6.3 Clinics 74 6.4 Homecare Settings 75 6.5 Ambulatory Surgical Centers (ASCs) 76 6.6 Other Settings 77 7 Segmentation of Global Market by Region 78 7.1 Geographic Market Overview 2021-2031 78 7.2 North America Market 2021-2031 by Country 82 7.2.1 Overview of North America Market 82 7.2.2 U.S. 86 7.2.3 Canada 90 7.2.4 Mexico 93 7.3 European Market 2021-2031 by Country 96 7.3.1 Overview of European Market 96 7.3.2 Germany 100 7.3.3 U.K. 103 7.3.4 France 106 7.3.5 Spain 109 7.3.6 Italy 112 7.3.7 Netherlands 115 7.3.8 Rest of European Market 118 7.4 Asia-Pacific Market 2021-2031 by Country 120 7.4.1 Overview of Asia-Pacific Market 120 7.4.2 Japan 124 7.4.3 China 128 7.4.4 Australia 131 7.4.5 India 134 7.4.6 South Korea 137 7.4.7 Rest of APAC Region 140 7.5 South America Market 2021-2031 by Country 142 7.5.1 Argentina 145 7.5.2 Brazil 148 7.5.3 Chile 151 7.5.4 Rest of South America Market 154 7.6 MEA Market 2021-2031 by Country 155 7.6.1 Israel 158 7.6.2 Saudi Arabia 161 7.6.3 South Africa 164 7.6.4 Other National Markets 167 8 Competitive Landscape 168 8.1 Overview of Key Vendors 168 8.2 New Product Launch, Partnership, Investment, and M&A 172 8.3 Company Profiles 173 Aero Pump GmbH 173 Allergan plc. 175 AptarGroup, Inc. 176 Becton, Dickinson and Company 177 Biocorp 178 Clearside Biomedical, Inc. 179 EyePoint Pharmaceuticals, Inc. 180 Gaplast GmbH 181 Gerresheimer AG 182 Jotteq Inc. 183 Kedalion Therapeutics, Inc. 184 Mati Therapeutics, Inc. 185 Nemera 186 Nipro Corporation 187 Ocular Therapeutix, Inc. 188 Ocumedic, Inc. 189 Owen Mumford 190 Re-Vana Therapeutics 191 Silgan Holdings Inc. 192 Terumo Corporation 193 Valeant Pharmaceuticals International Inc. (Bausch Health Company) 194 West Pharmaceutical Services, Inc. 195 RELATED REPORTS 196
List of Tables: Table 1. Snapshot of Global Ophthalmic Drug Delivery System Market in Balanced Perspective, 2021-2031 20 Table 2. World Economic Outlook, 2021-2031 25 Table 3. Main Product Trends and Market Opportunities in Global Ophthalmic Drug Delivery System Market 35 Table 4. Global Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 43 Table 5. Global Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 54 Table 6. Global Ophthalmic Drug Delivery System Market by Disease, 2021-2031, $ mn 62 Table 7. Global Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 72 Table 8. Global Ophthalmic Drug Delivery System Market by Region, 2021-2031, $ mn 80 Table 9. Leading National Ophthalmic Drug Delivery System Market, 2021 and 2031, $ mn 82 Table 10. North America Ophthalmic Drug Delivery System Market by Country, 2021-2031, $ mn 85 Table 11. U.S. Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 89 Table 12. U.S. Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 89 Table 13. U.S. Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 90 Table 14. Canada Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 92 Table 15. Canada Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 92 Table 16. Canada Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 93 Table 17. Mexico Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 95 Table 18. Mexico Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 95 Table 19. Mexico Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 96 Table 20. Europe Ophthalmic Drug Delivery System Market by Country, 2021-2031, $ mn 100 Table 21. Germany Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 102 Table 22. Germany Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 102 Table 23. Germany Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 103 Table 24. U.K. Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 105 Table 25. U.K. Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 105 Table 26. U.K. Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 106 Table 27. France Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 108 Table 28. France Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 108 Table 29. France Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 109 Table 30. Spain Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 111 Table 31. Spain Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 111 Table 32. Spain Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 112 Table 33. Italy Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 114 Table 34. Italy Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 114 Table 35. Italy Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 115 Table 36. Netherlands Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 117 Table 37. Netherlands Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 117 Table 38. Netherlands Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 118 Table 39. Ophthalmic Drug Delivery System Market in Rest of Europe by Country, 2021-2031, $ mn 120 Table 40. APAC Ophthalmic Drug Delivery System Market by Country, 2021-2031, $ mn 123 Table 41. Japan Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 127 Table 42. Japan Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 127 Table 43. Japan Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 128 Table 44. China Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 130 Table 45. China Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 130 Table 46. China Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 131 Table 47. Australia Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 133 Table 48. Australia Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 133 Table 49. Australia Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 134 Table 50. India Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 136 Table 51. India Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 136 Table 52. India Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 137 Table 53. South Korea Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 139 Table 54. South Korea Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 139 Table 55. South Korea Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 140 Table 56. Ophthalmic Drug Delivery System Market in Rest of APAC by Country/Region, 2021-2031, $ mn 142 Table 57. South America Ophthalmic Drug Delivery System Market by Country, 2021-2031, $ mn 145 Table 58. Argentina Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 147 Table 59. Argentina Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 147 Table 60. Argentina Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 148 Table 61. Brazil Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 150 Table 62. Brazil Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 150 Table 63. Brazil Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 151 Table 64. Chile Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 153 Table 65. Chile Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 153 Table 66. Chile Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 154 Table 67. MEA Ophthalmic Drug Delivery System Market by Country, 2021-2031, $ mn 158 Table 68. Israel Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 160 Table 69. Israel Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 160 Table 70. Israel Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 161 Table 71. Saudi Arabia Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 163 Table 72. Saudi Arabia Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 163 Table 73. Saudi Arabia Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 164 Table 74. South Africa Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 166 Table 75. South Africa Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 166 Table 76. South Africa Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 167 Table 77. Breakdown of World Market by Key Vendor, 2021, % 171 Table 78. Aero Pump GmbH: Company Snapshot 174 Table 79. Aero Pump GmbH: Business Segmentation 175 Table 80. Aero Pump GmbH: Product Portfolio 175
List of Figures: Figure 1. Research Method Flow Chart 14 Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 17 Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 19 Figure 4. Industry Value Chain Analysis 22 Figure 5. Global Ophthalmic Drug Delivery System Market, 2021-2031, $ mn 23 Figure 6. Impact of COVID-19 on Business 26 Figure 7. Primary Drivers and Impact Factors of Global Ophthalmic Drug Delivery System Market 28 Figure 8. Number of Population Affected by Vision Impairment, All Ages by Sex, 1990–2050F 31 Figure 9. Primary Restraints and Impact Factors of Global Ophthalmic Drug Delivery System Market 32 Figure 10. Investment Opportunity Analysis 36 Figure 11. Porter’s Fiver Forces Analysis of Global Ophthalmic Drug Delivery System Market 39 Figure 12. Breakdown of Global Ophthalmic Drug Delivery System Market by Product, 2021-2031, % of Revenue 44 Figure 13. Global Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 44 Figure 14. Global Ophthalmic Drug Delivery System Market by Product: Pre-filled Syringes, 2021-2031, $ mn 45 Figure 15. Global Ophthalmic Drug Delivery System Market by Product: Multidose Eyedroppers, 2021-2031, $ mn 46 Figure 16. Global Ophthalmic Drug Delivery System Market by Product: Squeeze Dispensers, 2021-2031, $ mn 47 Figure 17. Global Ophthalmic Drug Delivery System Market by Product: Mist Sprayers, 2021-2031, $ mn 48 Figure 18. Global Ophthalmic Drug Delivery System Market by Product: Contact Lenses, 2021-2031, $ mn 49 Figure 19. Global Ophthalmic Drug Delivery System Market by Product: Ocular Inserts, 2021-2031, $ mn 50 Figure 20. Global Ophthalmic Drug Delivery System Market by Product: Intraocular Implants, 2021-2031, $ mn 51 Figure 21. Global Ophthalmic Drug Delivery System Market by Product: Punctal Plugs, 2021-2031, $ mn 52 Figure 22. Global Ophthalmic Drug Delivery System Market by Product: Other Products, 2021-2031, $ mn 53 Figure 23. Breakdown of Global Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, % of Sales Revenue 55 Figure 24. Global Addressable Market Cap in 2022-2031 by Dosage Form, Value ($ mn) and Share (%) 55 Figure 25. Global Ophthalmic Drug Delivery System Market by Dosage Form: Solutions, 2021-2031, $ mn 56 Figure 26. Global Ophthalmic Drug Delivery System Market by Dosage Form: Gels, 2021-2031, $ mn 57 Figure 27. Global Ophthalmic Drug Delivery System Market by Dosage Form: Ointments, 2021-2031, $ mn 58 Figure 28. Global Ophthalmic Drug Delivery System Market by Dosage Form: Suspensions, 2021-2031, $ mn 59 Figure 29. Global Ophthalmic Drug Delivery System Market by Dosage Form: Emulsions, 2021-2031, $ mn 60 Figure 30. Global Ophthalmic Drug Delivery System Market by Dosage Form: Liposomes & Nanoparticles, 2021-2031, $ mn 61 Figure 31. Breakdown of Global Ophthalmic Drug Delivery System Market by Disease, 2021-2031, % of Sales Revenue 63 Figure 32. Global Addressable Market Cap in 2022-2031 by Disease, Value ($ mn) and Share (%) 63 Figure 33. Global Ophthalmic Drug Delivery System Market by Disease: Glaucoma, 2021-2031, $ mn 64 Figure 34. Global Ophthalmic Drug Delivery System Market by Disease: Diabetic Retinopathy, 2021-2031, $ mn 65 Figure 35. Global Ophthalmic Drug Delivery System Market by Disease: Cataract, 2021-2031, $ mn 66 Figure 36. Global Ophthalmic Drug Delivery System Market by Disease: Dry Eye Syndrome, 2021-2031, $ mn 67 Figure 37. Global Ophthalmic Drug Delivery System Market by Disease: Macular Degeneration, 2021-2031, $ mn 68 Figure 38. Global Ophthalmic Drug Delivery System Market by Disease: Diabetic Macular Edema, 2021-2031, $ mn 69 Figure 39. Global Ophthalmic Drug Delivery System Market by Disease: Refractive Issues, 2021-2031, $ mn 70 Figure 40. Global Ophthalmic Drug Delivery System Market by Disease: Other Diseases, 2021-2031, $ mn 71 Figure 41. Breakdown of Global Ophthalmic Drug Delivery System Market by Setting, 2021-2031, % of Revenue 73 Figure 42. Global Addressable Market Cap in 2022-2031 by Setting, Value ($ mn) and Share (%) 73 Figure 43. Global Ophthalmic Drug Delivery System Market by Setting: Hospitals, 2021-2031, $ mn 74 Figure 44. Global Ophthalmic Drug Delivery System Market by Setting: Clinics, 2021-2031, $ mn 75 Figure 45. Global Ophthalmic Drug Delivery System Market by Setting: Homecare Settings, 2021-2031, $ mn 76 Figure 46. Global Ophthalmic Drug Delivery System Market by Setting: Ambulatory Surgical Centers (ASCs), 2021-2031, $ mn 77 Figure 47. Global Ophthalmic Drug Delivery System Market by Setting: Other Settings, 2021-2031, $ mn 78 Figure 48. Global Market Snapshot by Region 79 Figure 49. Geographic Spread of Worldwide Ophthalmic Drug Delivery System Market, 2021-2031, % of Sales Revenue 80 Figure 50. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%) 81 Figure 51. North American Ophthalmic Drug Delivery System Market, 2021-2031, $ mn 84 Figure 52. Breakdown of North America Ophthalmic Drug Delivery System Market by Country, 2021 and 2031, % of Revenue 85 Figure 53. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 86 Figure 54. U.S. Ophthalmic Drug Delivery System Market, 2021-2031, $ mn 88 Figure 55. Canada Ophthalmic Drug Delivery System Market, 2021-2031, $ mn 91 Figure 56. Ophthalmic Drug Delivery System Market in Mexico, 2021-2031, $ mn 94 Figure 57. European Ophthalmic Drug Delivery System Market, 2021-2031, $ mn 98 Figure 58. Breakdown of European Ophthalmic Drug Delivery System Market by Country, 2021 and 2031, % of Revenue 99 Figure 59. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 100 Figure 60. Ophthalmic Drug Delivery System Market in Germany, 2021-2031, $ mn 101 Figure 61. Ophthalmic Drug Delivery System Market in U.K., 2021-2031, $ mn 104 Figure 62. Ophthalmic Drug Delivery System Market in France, 2021-2031, $ mn 107 Figure 63. Ophthalmic Drug Delivery System Market in Spain, 2021-2031, $ mn 110 Figure 64. Ophthalmic Drug Delivery System Market in Italy, 2021-2031, $ mn 113 Figure 65. Ophthalmic Drug Delivery System Market in Netherlands, 2021-2031, $ mn 116 Figure 66. Ophthalmic Drug Delivery System Market in Rest of Europe, 2021-2031, $ mn 119 Figure 67. Asia-Pacific Ophthalmic Drug Delivery System Market, 2021-2031, $ mn 122 Figure 68. Breakdown of APAC Ophthalmic Drug Delivery System Market by Country, 2021 and 2031, % of Revenue 122 Figure 69. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 124 Figure 70. Ophthalmic Drug Delivery System Market in Japan, 2021-2031, $ mn 126 Figure 71. Ophthalmic Drug Delivery System Market in China, 2021-2031, $ mn 129 Figure 72. Ophthalmic Drug Delivery System Market in Australia, 2021-2031, $ mn 132 Figure 73. Ophthalmic Drug Delivery System Market in India, 2021-2031, $ mn 135 Figure 74. Ophthalmic Drug Delivery System Market in South Korea, 2021-2031, $ mn 138 Figure 75. Ophthalmic Drug Delivery System Market in Rest of APAC, 2021-2031, $ mn 141 Figure 76. South America Ophthalmic Drug Delivery System Market, 2021-2031, $ mn 144 Figure 77. Breakdown of South America Ophthalmic Drug Delivery System Market by Country, 2021 and 2031, % of Revenue 144 Figure 78. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 145 Figure 79. Ophthalmic Drug Delivery System Market in Argentina, 2021-2031, $ mn 146 Figure 80. Ophthalmic Drug Delivery System Market in Brazil, 2021-2031, $ mn 149 Figure 81. Ophthalmic Drug Delivery System Market in Chile, 2021-2031, $ mn 152 Figure 82. Ophthalmic Drug Delivery System Market in Rest of South America, 2021-2031, $ mn 155 Figure 83. Ophthalmic Drug Delivery System Market in Middle East and Africa (MEA), 2021-2031, $ mn 157 Figure 84. Breakdown of MEA Ophthalmic Drug Delivery System Market by Country, 2021 and 2031, % of Revenue 157 Figure 85. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 158 Figure 86. Ophthalmic Drug Delivery System Market in Israel, 2021-2031, $ mn 159 Figure 87. Ophthalmic Drug Delivery System Market in Saudi Arabia, 2021-2031, $ mn 162 Figure 88. Ophthalmic Drug Delivery System Market in South Africa, 2021-2031, $ mn 165 Figure 89. Growth Stage of Global Ophthalmic Drug Delivery System Industry over the Forecast Period 169
Selected Key Players: Aero Pump GmbH Allergan plc. AptarGroup, Inc. Becton, Dickinson and Company Biocorp Clearside Biomedical, Inc. EyePoint Pharmaceuticals, Inc. Gaplast GmbH Gerresheimer AG Jotteq Inc. Kedalion Therapeutics, Inc. Mati Therapeutics, Inc. Nemera Nipro Corporation Ocular Therapeutix, Inc. Ocumedic, Inc. Owen Mumford Re-Vana Therapeutics Silgan Holdings Inc. Terumo Corporation Valeant Pharmaceuticals International Inc. (Bausch Health Company) West Pharmaceutical Services, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)